Daily Archives: 16/01/2011

Dabigatran Polymorphic patent application rejected

Dabigatran is an anticoagulant thrombin inhibitor marketed by Boehringer and marketed as Pradaxa. The Dabigatran’s product patent is granted in india (370/DEL/1998 granted as 225735). It is marketed as dabigatran etexilate mesylate. This mesylate salt form of dabigatran prodrug (etexilate) is protected … Continue reading

Posted in Daily interesting IP news | Leave a comment